Psychemedics Corp (PMD): רווח למניה בשנים עשר החודשים האחרונים
Net income per share dynamics confirm the resilience of Psychemedics (PMD), where the metric reached -0.51. The business relies on proprietary tests integrated into B2B compliance. High prestige and unique methodologies enable the company to attract leading toxicologists. Stability is maintained by low turnover among hair analysis experts, which eliminates personnel shortages.
פילוחים אנליטיים ודוחות נתונים של חברת Psychemedics Corp. (PMD)
For Psychemedics (PMD), a leader in high-precision hair analysis, the trailing 12-month net profit per share chart reflects the actual monetization efficiency of its diagnostic tools. This indicator is calculated by dividing the total annual net income by the total number of shares. The metric demonstrates the actual return on a single share of capital, stripped of one-off factors. It is critical for investors to distinguish organic profit growth from an artificial inflation of EPS through share buybacks. A stable trend confirms the resilience of the business model within the law enforcement testing segment.
